Stocktoria
Enovis CORP ENOV
NYSE · XNYS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2008-05-08
Enovis CORP statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 59.8% | 56.0% | 58.0% | 55.6% | 54.5% |
| Operating margin | -50.0% | -36.8% | -3.8% | -4.6% | -4.4% |
| Net margin | -52.7% | -39.2% | -1.9% | -0.9% | 5.0% |
| FCF margin | 0.9% | -3.2% | 0.7% | -10.3% | 17.7% |
| Return on assets | -30.9% | -17.5% | -0.7% | -0.3% | 0.8% |
| Return on equity | -79.4% | -32.2% | -1.0% | -0.4% | 1.5% |
| Debt / equity | 0.87× | 0.52× | 0.14× | 0.08× | 0.45× |
| Current ratio | 2.02 | 2.17 | 2.43 | 1.41 | 2.25 |
| Revenue growth | 6.7% | 23.5% | 9.2% | 9.6% | 27.3% |
Source: SEC EDGAR filings · CIK 0001420800 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.